Kyntra Bio KYNB
NASDAQ KYNB
$5.21 -0.14 (-2.70%)
At close: Oct 21, 2026 · 4:00 PM EDT

Kyntra Bio (KYNB) EV to EBIT (2019)

Updated

Kyntra Bio's (KYNB) EV to EBIT stood at 84.26 in Q3 2019, up 5.6% from the prior quarter.

Analysis

Kyntra Bio (KYNB) EV to EBIT (2019) Analysis & Trends

On a TTM basis, Kyntra Bio's EV to EBIT came in at 24.75 as of Sep 30, 2019.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Kyntra Bio 21.25 Mn -386.69 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 84.26
Jun 30, 2019 79.81
API Access

Kyntra Bio EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=KYNB&period=max&api_key=YOUR_API_KEY